BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 37086156)

  • 21. Cerebrospinal fluid metabolomics identifies a key role of isocitrate dehydrogenase in bipolar disorder: evidence in support of mitochondrial dysfunction hypothesis.
    Yoshimi N; Futamura T; Bergen SE; Iwayama Y; Ishima T; Sellgren C; Ekman CJ; Jakobsson J; Pålsson E; Kakumoto K; Ohgi Y; Yoshikawa T; Landén M; Hashimoto K
    Mol Psychiatry; 2016 Nov; 21(11):1504-1510. PubMed ID: 26782057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In silico gene expression analysis reveals glycolysis and acetate anaplerosis in IDH1 wild-type glioma and lactate and glutamate anaplerosis in IDH1-mutated glioma.
    Khurshed M; Molenaar RJ; Lenting K; Leenders WP; van Noorden CJF
    Oncotarget; 2017 Jul; 8(30):49165-49177. PubMed ID: 28467784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tricarboxylic acid cycle enzyme activities in a mouse model of methylmalonic aciduria.
    Wongkittichote P; Cunningham G; Summar ML; Pumbo E; Forny P; Baumgartner MR; Chapman KA
    Mol Genet Metab; 2019 Dec; 128(4):444-451. PubMed ID: 31648943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolomics and transcriptomics profiles reveal the dysregulation of the tricarboxylic acid cycle and related mechanisms in prostate cancer.
    Shao Y; Ye G; Ren S; Piao HL; Zhao X; Lu X; Wang F; Ma W; Li J; Yin P; Xia T; Xu C; Yu JJ; Sun Y; Xu G
    Int J Cancer; 2018 Jul; 143(2):396-407. PubMed ID: 29441565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple metabolic pathways fuel the truncated tricarboxylic acid cycle of the prostate to sustain constant citrate production and secretion.
    Frégeau-Proulx L; Lacouture A; Berthiaume L; Weidmann C; Harvey M; Gonthier K; Pelletier JF; Neveu B; Jobin C; Bastien D; Bergeron A; Fradet Y; Lacombe L; Laverdière I; Atallah C; Pouliot F; Audet-Walsh É
    Mol Metab; 2022 Aug; 62():101516. PubMed ID: 35598879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IDH2 reprograms mitochondrial dynamics in cancer through a HIF-1α
    Wang Y; Agarwal E; Bertolini I; Ghosh JC; Seo JH; Altieri DC
    FASEB J; 2019 Dec; 33(12):13398-13411. PubMed ID: 31530011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NADP(+)-IDH Mutations Promote Hypersuccinylation that Impairs Mitochondria Respiration and Induces Apoptosis Resistance.
    Li F; He X; Ye D; Lin Y; Yu H; Yao C; Huang L; Zhang J; Wang F; Xu S; Wu X; Liu L; Yang C; Shi J; He X; Liu J; Qu Y; Guo F; Zhao J; Xu W; Zhao S
    Mol Cell; 2015 Nov; 60(4):661-75. PubMed ID: 26585387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting isocitrate dehydrogenase (IDH) in cancer.
    Fujii T; Khawaja MR; DiNardo CD; Atkins JT; Janku F
    Discov Med; 2016 May; 21(117):373-80. PubMed ID: 27355333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alternol eliminates excessive ATP production by disturbing Krebs cycle in prostate cancer.
    Li C; He C; Xu Y; Xu H; Tang Y; Chavan H; Duan S; Artigues A; Forrest ML; Krishnamurthy P; Han S; Holzbeierlein JM; Li B
    Prostate; 2019 May; 79(6):628-639. PubMed ID: 30663084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assembly and function of a cytosolic form of NADH-specific isocitrate dehydrogenase in yeast.
    Zhao WN; McAlister-Henn L
    J Biol Chem; 1996 Apr; 271(17):10347-52. PubMed ID: 8626605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isocitrate dehydrogenase (IDH), succinate dehydrogenase (SDH), fumarate hydratase (FH): three players for one phenotype in cancer?
    Laurenti G; Tennant DA
    Biochem Soc Trans; 2016 Aug; 44(4):1111-6. PubMed ID: 27528759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glioma cells with the IDH1 mutation modulate metabolic fractional flux through pyruvate carboxylase.
    Izquierdo-Garcia JL; Cai LM; Chaumeil MM; Eriksson P; Robinson AE; Pieper RO; Phillips JJ; Ronen SM
    PLoS One; 2014; 9(9):e108289. PubMed ID: 25243911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolic adaptations in cancers expressing isocitrate dehydrogenase mutations.
    Hvinden IC; Cadoux-Hudson T; Schofield CJ; McCullagh JSO
    Cell Rep Med; 2021 Dec; 2(12):100469. PubMed ID: 35028610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screen for IDH1, IDH2, IDH3, D2HGDH and L2HGDH mutations in glioblastoma.
    Krell D; Assoku M; Galloway M; Mulholland P; Tomlinson I; Bardella C
    PLoS One; 2011; 6(5):e19868. PubMed ID: 21625441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic changes related to the IDH1 mutation in gliomas preserve TCA-cycle activity: An investigation at the protein level.
    Dekker LJM; Wu S; Jurriëns C; Mustafa DAN; Grevers F; Burgers PC; Sillevis Smitt PAE; Kros JM; Luider TM
    FASEB J; 2020 Mar; 34(3):3646-3657. PubMed ID: 31960518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adaptive Evolution of the GDH2 Allosteric Domain Promotes Gliomagenesis by Resolving IDH1
    Waitkus MS; Pirozzi CJ; Moure CJ; Diplas BH; Hansen LJ; Carpenter AB; Yang R; Wang Z; Ingram BO; Karoly ED; Mohney RP; Spasojevic I; McLendon RE; Friedman HS; He Y; Bigner DD; Yan H
    Cancer Res; 2018 Jan; 78(1):36-50. PubMed ID: 29097607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reverse TCA cycle flux through isocitrate dehydrogenases 1 and 2 is required for lipogenesis in hypoxic melanoma cells.
    Filipp FV; Scott DA; Ronai ZA; Osterman AL; Smith JW
    Pigment Cell Melanoma Res; 2012 May; 25(3):375-83. PubMed ID: 22360810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome.
    Reitman ZJ; Jin G; Karoly ED; Spasojevic I; Yang J; Kinzler KW; He Y; Bigner DD; Vogelstein B; Yan H
    Proc Natl Acad Sci U S A; 2011 Feb; 108(8):3270-5. PubMed ID: 21289278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of a novel inactivating mutation in Isocitrate Dehydrogenase 1 (IDH1-R314C) in a high grade astrocytoma.
    van Lith SA; Navis AC; Lenting K; Verrijp K; Schepens JT; Hendriks WJ; Schubert NA; Venselaar H; Wevers RA; van Rooij A; Wesseling P; Molenaar RJ; van Noorden CJ; Pusch S; Tops B; Leenders WP
    Sci Rep; 2016 Jul; 6():30486. PubMed ID: 27460417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kinetic and physiological effects of alterations in homologous isocitrate-binding sites of yeast NAD(+)-specific isocitrate dehydrogenase.
    Lin AP; McCammon MT; McAlister-Henn L
    Biochemistry; 2001 Nov; 40(47):14291-301. PubMed ID: 11714283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.